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SARS 
Though the epidemic of SARS, which infected more than 8000 people on several continents, has been controlled as a result of public health 
interventions, there remain major concerns about the possibility of re-emergence of this newly identified zoonosis. 
A single case of SARS was diagnosed in a laboratory worker in Singapore (ProMED-mail archive number 20030923.2397). Infection with 
the SARS-associated coronavirus (SARS-CoV) was confirmed on the basis of stool and sputum specimens that were positive by reverse 
transcriptase polymerase chain reaction (RT-PCR) and confirmed by two other laboratories. Acute and convalescent serum samples also 
demonstrated seroconversion to the virus.There has been no evidence of secondary spread. A detailed inquiry conducted by an ll-member review 
panel considered a variety of possible explanations. Evidence in favor of a laboratory-acquired infection included the following: 
The patient worked in the biosafety level 3 (BSL-3) laboratory 3.5 days before the onset of his illness. This timing is consistent with the 
incubation period for SARS. Although the patient reported working only on West Nile virus, the laboratory was conducting live SARS 
work around that time. 
Poor record-keeping makes it difficult to ascertain whether there was live virus in the BSL-3 laboratory on the day of the patient’s visit, 
but it was present 2 days prior to the day of his visit. 
Testing of the frozen specimen that the patient worked with in the laboratory on 23 August 2003 was positive by RT-PCR for the SARS- 
CoV and West Nile virus, suggesting contamination. 
The laboratory works on only one strain of the SARS coronavirus. Approximately 91% of the genome was sequenced from the patient 
and was found to be most closely related to the sequence of the laboratory strain. Minor differences observed are thought likely to result 
from the natural mutation rate for the virus. 
Another concern, that the virus could again ‘jump’ the species barrier, was addressed in MMWR 2003; 52(41):986-987. This reported an 
investigation conducted by public health authorities in Guangdong Province that compared the seroprevalence of SARS-CoV IgG antibody in 
animal traders (i.e. workers in live animal markets) with that of persons in control groups. In this study, 13% of the animal traders, none of whom 
had SARS diagnosed, had IgG antibody to SARS-CoV, compared with 1-3 % of persons in three control groups. Although there were limitations 
as a result of the study design, the report ‘provides indirect support for the hypothesis that SARS-CoV might have originated from an animal 
source’. 
West Nile virus 
Since its introduction into the USA in 1999, West Nile virus (WNV) has rapidly expanded its geographic range, from the metropolitan New York 
area in 1999 to essentially all of the USA and much of Canada, with foci in Mexico and the Caribbean. 
In the USA during 2002, there were 4156 human cases of WNV infection, and the virus was identified in 44 states. This year, including reports 
up to 15 October 2003 (MMWR 2003; 52(41):996-997), 6957 human cases of WNV infection have been reported. The states with the greatest 
number of cases are in the American west, most notably Colorado (2170), Nebraska (1108), South Dakota (930),Texas (421), North Dakota (375), 
Wyoming (320), Montana (214) and New Mexico (190). 
In Canada (ProMED-mail archive number 20031015.260) during 2002, there were 416 probable or confirmed cases of human WNV infection, 
and 21 deaths attributed to the virus. All the deaths and most of the cases occurred in Ontario and Quebec. This year, including reports up to 15 
October 2003, there have been 1217 probable or confirmed cases of human infection in Canada and 10 deaths. Saskatchewan has the greatest 
number of cases (709 probable or confirmed cases and six deaths), followed by Alberta (252 confirmed cases and no deaths). 
In Mexico (ProMED-mail archive number 20031008.2525), including reports up to 6 October 2003, there have been four human cases 
identified on the basis of serologic testing.Three were in the state of Chihuahua, and one (confirmed by RT-PCR) in the state of Sonora.Although 
4472 horses from 20 of the 32 states have been tested for evidence of WNV infection, with 1453 found to be seropositive, and 65 birds have been 
found to be seropositive, the lower incidence of disease and mortality in Mexico in the case of animals that have tested seropositive for WNV 
infection raises a number of questions. These include the possible existence of cross-reactivity in the serologic assay as a result of infection with 
other related flaviviruses, in terms of both conferring protection to WNV and causing false-positive results. 
In the Caribbean Islands (ProMED-mail archive number 20031011.2560), there have been reports of WNV infection in the Dominican 
Republic (birds), Jamaica (birds), and Guadeloupe (horses and birds). Whether these reports are due to viral isolation or serologic testing is not 
clear. 
Rabies in bats in Scotland 
Following on from last year’s fatal case of rabies in Scotland, which we reported in ‘ProMED Update’ in the March issue of Int J Infect Dis, a 
study by Scottish Natural Heritage has discovered that 10% of Daubenton’s bats have antibodies to European bat lyssavirus type 2 (EBLV2) 
(ProMED-mail archive number 20031003.2490). This is the same virus that caused the rabies-like illness which turned out to be fatal in the bat 
handler last November. This was the first ever confirmed case of human infection with EBLV2 in the UK, and the first human rabies-like infection 
acquired in the UK since 1902. 
The recent study in Scotland also examined samples of blood and saliva from 171 live bats for the presence of live infectious EBLVZ. All 
samples were negative, confirming that infectious EBLV is still very rare in the UK. Surveillance studies carried out by the Veterinary Laboratories 
Agency for the past 15 years, whereby up to 200 bats are tested annually, have detected only two cases of live bat rabies virus infection. Both of 
these cases, in 1996 and 2002, were in Daubenton’s bats that were found to be carrying EBLV2. The recent data from Scotland do not alter this 
situation, as the bats only tested positive for the antibodies, not for the infectious virus. 
242 International Journal of Infectious Diseases I Volume 7, Number 4,2003 
It is curious that a bat can have antibodies to a disease that is believed to be fatal to bats, without testing positive for live virus. A statement 
from the Bat Conservation Trust which was posted on ProMED-mail (archive number 20031003.2490) proposed five possible explanations: (1) 
the bat is infected and is/is not yet showing rabies symptoms; (2) the bat has recovered from a rabies infection (this is believed to be unlikely and 
rare); (3) the bat has been challenged by some component of the virus that has induced an antibody reaction but has not resulted in an infection; 
(4) the bat has acquired antibodies from its mother’s milk (short-lived benefit); and (5) the bat was challenged while it had the acquired antibodies 
from its mother and then produced its own antibody defense (the mother having antibodies for reasons 1,2 or 3). 
The discovery of antibodies to EBLV2 in bats in Scotland does not affect the UK’s rabies-free status. Experts from the Bat Conservation 
Trust have said that the risk to the public from bats remains ‘minimal’, and advice on how to minimize any risk from bats remains unchanged. 
Pertussis in Sudan 
Reports on ProMED-mail in early October estimated that 175 children had died of whooping cough in Kimatong Budi county, Equatoria state, 
Sudan (ProMED-mail archive number 20031008.2530). This outbreak included almost 1000 suspected cases, of which 860 had been confirmed. 
Most of those infected were under 5 years old. In addition, 82 people suffering from whooping cough also tested positive for malaria. 
It seems that there has been no non-governmental organization (NGO) presence in this area of Sudan for the last 5 years, and there is only 
one health facility in operation, with limited medicines and no laboratory facilities. Routine immunization (DTP) should be administered at ages 
6,lO and 14 weeks, but the vaccination program has suffered recently. Chronic malaria and ongoing rains (bringing further mosquitoes) make 
the situation worse. 
Medair and Tearfund are carrying out health education programs in the area. A mass treatment and prevention campaign has begun in 
several locations around the villages of Chawa, Kimatong, Thurunge, and Kali, and whole families are being treated after one member has become 
infected. 
Outbreaks of pertussis do not only affect developing countries. In July 2003, more than 40 confirmed cases of whooping cough were reported 
in Georgetown County, South Carolina, USA (ProMED-mail archive number 20030716.1750). Spikes in the incidence of pertussis were also 
reported in Pierce County, Washington State and Albany County, New York State last year (ProMED-mail archive number 20030624.1554). 
Experts say that it is not unusual to see small outbreaks of pertussis throughout the USA each year. These tend to occur in unvaccinated or 
incompletely vaccinated children (including those less than 1 year old who have not yet completed their immunization) and older children and 
adults in whom vaccine immunity has waned. 
Data from the Centers for Disease Control and Prevention confirm that the overall epidemiology of pertussis in the USA is changing. 
Reported incidence rates in adults have increased by 400% from 1990 to 2001. In 2002,8296 cases were provisionally reported by the CDC. The 
reported massive increase in incidence rates in the USA could be due to a change in reporting, a true increase in incidence, or both. One of the 
main factors is likely to be waning vaccine-induced immunity, which has increased susceptibility to infection in both adults and adolescents. Other 
contributory factors include non-vaccination of children, incomplete vaccination of children, and primary vaccine failure. Changing from the DTP 
vaccine to the acellular DTaP vaccine has reduced the problem of reactogenicity but does not appear to have greatly increased immunogenicity. 
The acellular pertussis vaccine is well tolerated in adults, and may be beneficial in the outbreak situation. 
Plague 
In the last issue of Znt J Infect Dis, we wrote about plague in Algeria. Plague is still endemic in many other countries of the world, and most of 
the world’s plague cases are reported from Africa. There have been several reports on ProMED mail in the last few months of plague in Central 
Asia.Three cases of bubonic plague acquired through contact with the meat of an infected camel were reported in west Kazakhstan in Mangistausk 
region at the end of July (ProMED-mail archive number 20030801.1881). Plague is enzootic in wild rodents in Central and South-east Asia, and 
camels become infected by coming into contact with infected rodents. In September, a 4-year-old girl from the village of Shomish, near Aralsk in 
the Kzyl-Orda region of Kazakhstan, died from bubonic plague (ProMED-mail archive number 20030822.2119). She had been infected after a 
flea bite, and further epidemiologic investigations revealed no other cases. 
Mongolia reported three cases of plague (none fatal) at the end of August (ProMED-mail archive number 20030908.2255). Plague is endemic 
in Mongolia, and human cases of bubonic plague are reported in most years, mainly in people who live in rural areas and hunt marmots for their 
fur. 
It is important to note that plague may recur in areas that were at one time free of the disease. Mortality is high if the disease is untreated, 
especially in cases of pneumonic plague. However, with rapid diagnosis and appropriate treatment (e.g. with antibiotics such as streptomycin and 
tetracycline), mortality may be reduced from approximately 60% to less than 15%. 
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